An Overview on the Integrity of COVID-19 Health Decisions
Abstract:
The COVID-19 pandemic opened an unprecedent debate that was often hampered by censorship, especially in the area of the ‘COVID-19 vaccines’ effectiveness and role of public health authorities and medical products regulatory agencies. Another controversy that is slowly being resolved by new available facts is the origin of SARS-CoV-2. Indeed, a critical review of recent developments points to a possible misuse of medical information and involvement of public health officials in misleading the public about the nature and management of the pan demic. Moreover, the introduction of recombinant technology-based vaccines against COVID-19, strongly pushed by authorities as the primary solution to the proclaimed pandemic, increasingly raises concerns over their safety and efficacy. This is substantiated by a number of patents and published scientific research pre-dating the pan demic that suggest the possibility of a prior manipulation of viral proteins, including spike protein with a goal of development of new products such as vaccines, for global marketing. Despite some early studies and medical groups during 2020 and 2021 reported on existing drugs showing potential efficacy in treating COVID-19, the focus shifted towards emergency vaccine use, leading to the approval of untested vaccine technology on the whole population. Importantly, scientific evaluations of vaccine impacts are still hampered by unreliable data, unclear cases numbers, and unreliable mortality calculations. At last, the term "long-COVID" has been confused with the post-vaccination syndrome, and adverse effects from vaccines are more evident as evidenced by the scientific literature. Regulatory agencies, such as the FDA and EMA, have faced criticism for approving the ‘COVID-19 vaccines’ without adequate safety evaluation and for not adequately addressing post-vaccination complications. As the evidence on these complications rises, the necessity for further investigation into the safety and efficacy of COVID-19 vaccines remains urgent.
